Item 8.01. Other Events

On January 4, 2023, Dyadic International, Inc. ("Dyadic" or the "Company") posted a presentation entitled "Next Generation Proteins for World Health" on the Company's website at www.dyadic.com under the "Investors" tab. On January 4, 2023, Dyadic also issued a press release announcing that senior executive management will attend the J.P. Morgan 41st Annual Healthcare Conference in San Francisco, CA. Dyadic's founder and CEO, Mark Emalfarb will be making a corporate presentation at 4:00 PM PT on January 8, 2023 at the 6th Annual BFC Global Healthcare BD and Investment Conference, San Francisco, CA. Mr. Emalfarb will also be participating on the opening panel, which is scheduled at 9:15-10:15 AM PT.

The presentation highlights the recent advancements Dyadic has made with its C1-cell protein expression platform including the initiation of its first in human Phase 1 program for an antigen expressed in the C1 platform, with the trial expected to begin in early January 2023.

Representatives of Dyadic will use the presentation in industry conferences, investor conferences and investor meetings from time to time. A copy of the press release is filed as Exhibit 99.1 and a copy of the presentation is also attached hereto as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.




Item 9.01 Financial Statements and Exhibits
(d) Exhibits
The following exhibit is being furnished herein:
      Exhibit
      Number          Description

       99.1             Dyadic International Press Release Dated January 4, 2023
       99.2             Dyadic International Presentation, "Next Generation
                      Proteins for World Health", dated January 4, 2023
        104           Cover page Interactive Data File (embedded within the Inline
                      XBRL document)

© Edgar Online, source Glimpses